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Abstract K-Tocopherol (vitamin E) is an important fat-soluble
antioxidant in biological systems and, as a result of scavenging
reactive oxygen, it is converted to K-tocopherylquinone. K-
Tocopherol binds to K-tocopherol transfer protein (KTTP) in the
liver cytosol, whereas K-tocopherylquinone does not. We found
that K-tocopherylquinone binds to a liver protein with a
molecular mass of about 40 kDa that is distinct from KTTP.
This K-tocopherylquinone binding protein was purified further by
multiple-step column chromatography. Sodium dodecylsulfate-
polyacrylamide gel electrophoresis of the final preparation
yielded a single band with an apparent molecular mass of
25 kDa, which microsequencing revealed was identical to
glutathione-S-transferase (GST). The GST activity was inhibited
in the presence of K-tocopherylquinone, as it is by other non-
substrate ligands for GST, confirming that GST and
K-tocopherylquinone interact directly. K-Tocopherylquinone
binds to GST and may be transported to the site of metabolism
or excreted in the bile as other non-substrate ligands for GST.
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1. Introduction
K-Tocopherol (vitamin E) is an important anti-oxidant in
biological systems [1]. It inhibits peroxidation of membrane
lipids by scavenging lipid peroxyl radicals, as a consequence
of which it is converted into a tocopheroxyl radical. This
radical is thought to be either recycled to K-tocopherol by
interacting with soluble antioxidants, such as ascorbic acid,
or irreversibly oxidized to K-tocopherylquinone. In fact,
K-tocopherylquinone has been detected in a variety of tissues
[2,3], and it may act as a potent anticoagulant [4], and as an
antioxidant through its reduction to hydroquinone [5]. There-
fore, it is important to understand the mechanism responsible
for the metabolism of K-tocopherylquinone in the body,
although little is known about this at present.
The liver cytosol contains a speci¢c K-tocopherol binding
protein, which is referred to as the K-tocopherol transfer pro-
tein (KTTP). We puri¢ed this protein and isolated its cDNA
from rats and humans [6^8], and demonstrated that KTTP is a
product of the causative gene of familial isolated vitamin E
de¢ciency [9^11]. These studies established that KTTP in the
liver cytosol stimulates the secretion of K-tocopherol taken up
by the liver into the general circulation.
KTTP binds speci¢cally to K-tocopherol and enhances its
transfer between membranes, but it does not bind to K-toco-
pherylquinone to any appreciable extent [12]. In this study, we
found that K-tocopherylquinone binds to a liver cytosolic pro-
tein distinct from KTTP, and identi¢ed this protein as gluta-
thione-S-transferase (GST).
2. Materials and methods
2.1. Materials
D-[3H]K-Tocopherol (9.8 Ci/mmol) was purchased from Amersham
International. D-K-Tocopherol and K-tocopherylquinone were kindly
provided by Eisai (Tokyo). Sephacryl S-200, DEAE Sepharose CL-
6B, CM Sepharose CL-6B, PBE118 and Pharmalyte were purchased
from Pharmacia Biotech. Hydroxyapatite and goat anti-mouse IgG
monoclonal antibody conjugated with alkaline phosphatase were pur-
chased from Bio-Rad. Bromosulfophthalein and pregnenolone were
purchased from Sigma.
2.2. Preparation of [3H]K-tocopherylquinone
D-[3H]K-Tocopherol (1 Ci/mmol, 400 Wg) was dissolved in diethyl
ether (400 Wl), 100 mg FeCl3 in 400 Wl acetone was added and the
mixture was stirred at room temperature for 30 min. Diethyl ether
(750 Wl) was added to the reaction mixture, which was washed twice
with water (750 Wl), the ether layer was dried over Na2SO4 and con-
centrated by evaporation. The crude product was puri¢ed by prepa-
rative thin-layer chromatography with chloroform, and the compound
at Rf 0.25 was scratched o¡ the plate, extracted with ethyl acetate,
and its radioactivity was counted using a liquid scintillation counter.
2.3. Preparation of rat liver cytosol
The pooled supernatant fraction obtained after centrifuging liver
homogenates at 100 000Ug was precipitated with 90% (w/v) ammo-
nium sulfate, the precipitate was dissolved in a small volume of SET
bu¡er (250 mM sucrose, 1 mM EDTA, 10 mM Tris-HCl, pH 7.4) and
dialyzed against 20 mM Tris-HCl, 1 mM EDTA, pH 7.2.
2.4. Assay of [3H]K-tocopherylquinone and [3H]K-tocopherol binding
activity
Binding activities of [3H]K-tocopherylquinone and [3H]K-tocopherol
by rat liver cytosol were evaluated by the method of Sato et al. [6],
with slight modi¢cations. [3H]K-Tocopherylquinone or [3H]K-toco-
pherol (2 WCi/number of rats) in 10 Wl ethanol per ml liver cytosol
sample, was added to aliquots of the sample, the mixtures were in-
cubated at room temperature for 30 min and subjected to Sephacryl
S-200 column chromatography, as described below.
2.5. Puri¢cation procedures
Four-milliliter aliquots of the samples described above were applied
to a Sephacryl S-200 column (2.5U95 cm) equilibrated with 10 mM
KH2PO4, 5 mM 2-mercaptoethanol, 10% (v/v) glycerol, pH 6.8 (bu¡er
A) and eluted with this bu¡er at a £ow rate of 10 ml/h. The active
fraction was applied to a DEAE Sepharose CL-6B column (1.5U
14 cm) equilibrated with bu¡er A and the £ow-through fraction eluted
with bu¡er A was collected, its pH was adjusted to 6.5 with HCl and
it was applied to a CM Sepharose CL-6B (1.5U12 cm) column equil-
ibrated with bu¡er A, pH 6.5. The protein was eluted with a linear
gradient of 0^150 mM NaCl in bu¡er A, pH 6.5. The active fraction
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from the CM Sepharose CL-6B column was applied to a hydroxy-
apatite column (1.5U6 cm) equilibrated with bu¡er A, and the protein
was eluted with a linear gradient of 10^200 mM KH2PO4 in bu¡er A.
2.6. Amino acid sequence
The amino-terminal sequence of the puri¢ed protein (40 Wg) was
analyzed using a gas-phase sequenator model 470A (Applied Biosys-
tems).
2.7. Western blot analysis
Proteins were separated by sodium dodecylsulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) [13], then transferred to a nitrocellu-
lose membrane using a Bio-Rad blotting apparatus and Western blot-
ting using the anti-KTTP monoclonal antibody AT-R1 (see [7]) was
carried out after blocking the nitrocellulose membrane with 3% (w/v)
gelatin overnight. After incubation with the antibody for 1 h, the
membrane was washed and incubated with goat anti-mouse IgG
monoclonal antibody conjugated with alkaline phosphatase for 1 h
at room temperature. After washing, the blot was developed in a
bu¡er (100 mM NaHCO3, 1 mM MgCl2, pH 9.8) containing 300 Wg/
ml nitroblue tetrazolium and 150 Wg/ml 5-bromo-4-chloro-3-indolyl
phosphate.
2.8. Assay of glutathione-S-transferase activity
GST activity was measured as described elsewhere [14] with slight
modi¢cations. The reaction was performed using 1 mM glutathione
and 2 mM 1-chloro-2,4-dinitrobenzene in 100 mM sodium phosphate,
pH 6.5, at 37‡C, and was monitored spectrophotometrically by re-
cording the increase in absorbance at 340 nm. K-Tocopherylquinone
in 10 Wl ethanol per 2 ml reaction mixture was added to determine its
e¡ect on GST activity. Bromosulfophthalein and pregnenolone were
used as positive and negative controls, respectively.
3. Results
The [3H]K-tocopherylquinone binding activity of rat liver
cytosol was determined by Sephacryl S-200 column chroma-
tography (Fig. 1). Peak K-tocopherylquinone binding activity
was detected in the fractions corresponding to a molecular
mass of 40 kDa, clearly di¡erent from the fraction showing
peak K-tocopherol binding activity (30 kDa). The K-tocopher-
ylquinone binding activity was eluted as a single peak by
subsequent sequential chromatography using DEAE-Sephar-
ose CL-6B and CM-Sepharose CL-6B columns. Subsequent
hydroxyapatite column chromatography separated the [3H]K-
tocopherylquinone binding activity into two peaks. SDS-
PAGE of these fractions revealed that peak I yielded a
23-kDa band and peak II yielded a 25-kDa band (Fig. 2)
and the activities of these peaks paralleled the intensities of
these bands.
The N-terminal amino acid sequence of the puri¢ed protein
(peak II) was determined and found to be PM(I/T)LGYW(N/
D)(V/I)RGL(T/A)H(P/A)IRL(L/F)L. A search using a protein
sequence data bank indicated that these sequences were iden-
tical to those of a mixture of N-terminal amino acid sequences
of the Yb1 and Yb2 subunits of GST. The GSTs are homo- or
heterodimers comprising multiple subunits and GST class mu,
which consists of homo- and heterodimers of Yb1 and Yb2
subunits, is present at a high concentration in the liver (up to
5% of the total soluble protein). Peak I was identi¢ed as a
GST of class alpha (data not shown).
GSTs are a family of proteins that catalyze the conjugation
of glutathione with various electrophils, many of which are
toxic [15]. In addition, GSTs bind to a variety of hydrophobic
compounds which do not undergo metabolism, such as bili-
rubin, bile acids and indocyanine green. Moreover, binding of
these non-substrate ligands to GST results in inhibition of the
catalytic activity of GST [16^18]. Therefore, we examined the
e¡ects of K-tocopherylquinone on the GST activities of peaks
I and II. As shown in Fig. 3, the transferase activities of both
peaks I and II were inhibited by K-tocopherylquinone in a
concentration dependent manner. Bromosulfophthalein, a
known non-substrate ligand of GST, was used as a positive
control, and inhibited the GST activities of the peaks, whereas
pregnenolone, which is not a ligand of GST, did not. These
results con¢rm that GST and K-tocopherylquinone interact
directly.
4. Discussion
In this study, we puri¢ed K-tocopherylquinone binding pro-
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Fig. 1. Sephacryl S-200 column chromatographic elution pro¢les of
rat liver cytosolic [3H]K-tocopherol and [3H]K-tocopherylquinone
binding activities. Rat liver cytosol samples were incubated for 30
min at room temperature in the presence of [3H]K-tocopherol or
[3H]K-tocopherylquinone (2 WCi/number of rats in 10 Wl ethanol per
ml sample) eluted from a Sephacryl S-200 column with bu¡er A.
The fractions were collected, examined for K-tocopherol (b) and
K-tocopherylquinone (a) binding activities and then subjected to
SDS-PAGE, followed by immunoblotting with the anti-rat KTTP
monoclonal antibody AT-R1.
Fig. 2. Hydroxyapatite column chromatographic elution pro¢le of
[3H]K-tocopherylquinone binding activity. The active fractions eluted
from the CM-Sepharose CL-6B column were pooled and then ap-
plied to a hydroxyapatite column equilibrated with bu¡er A, the
column was washed with this bu¡er and elution was carried out
with a linear gradient of KH2PO4 (10^200 mM) in this bu¡er. The
fractions were collected, examined for [3H]K-tocopherylquinone
binding activity and then subjected to SDS-PAGE, after which the
gel was stained with Coomassie Brilliant Blue.
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tein from rat liver cytosol and identi¢ed it as GST, which is a
multifunctional protein that functions both as an enzyme that
catalyzes glutathione conjugation and an intracellular binding
protein of various non-substrate ligands. GSTs are homo- or
heterodimers comprising multiple subunits and GST class mu,
which consists of homo- and heterodimers of Yb1 and Yb2
subunits, represented the principal intracellular K-tocopheryl-
quinone binding protein in the rat liver.
It has long been postulated that GST plays a role in cellular
transport, carrying hydrophobic non-substrate ligands
through the cytosol to intracellular sites of metabolism. There
is evidence to suggest that GST facilitates the movement of
heme out of mitochondria [19], GST class mu has been im-
plicated in the transport of steroid hormones to the cell nu-
cleus [20] and GST may deliver bilirubin to the site of metab-
olism within the cell [21]. K-Tocopherylquinone is the primary
hepatic oxidation product of K-tocopherol and is present in
rat liver at low concentrations. K-Tocopherylquinone is re-
duced to a hydroquinone, which may be conjugated with glu-
curonic acid and excreted in the bile [22]. However, neither
the molecular mechanism responsible nor how it is regulated
have been elucidated. In view of the results of this study, we
speculate that GSTs are involved in the delivery of K-toco-
pherylquinone to the site of its metabolism.
In the liver, K-tocopherol and K-tocopherylquinone bind to
two di¡erent cytosolic proteins. K-Tocopherol binds to KTTP,
which is thought to be a critical factor in determining the
plasma K-tocopherol level by virtue of its function of recycling
K-tocopherol from the liver [23]. Recently, we demonstrated
that KTTP stimulated the secretion of K-tocopherol by a
hepatoma cell line [24]. In contrast, K-tocopherylquinone
binds to GST and may be transported to the site of metabo-
lism or excreted in the bile. Such a cellular mechanism for
distinguishing between K-tocopherol and K-tocopherylquinone
may exist in the liver and our ¢ndings may provide a clue for
our understanding of the metabolic pathway of K-tocopher-
ylquinone.
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Fig. 3. E¡ect of K-tocopherylquinone on GST activity. The GST ac-
tivity was measured by following the reaction between 1 mM gluta-
thione and 2 mM 1-chloro-2,4-dinitrobenzene in 100 mM sodium
phosphate, pH 6.5. K-Tocopherylquinone (a), bromosulfophthalein
(U), or pregnenolone (R) was added to determine their e¡ects on
GST activity. Each point denotes the mean þ S.E. of three experi-
ments.
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